Previous close | 1.0700 |
Open | 1.0700 |
Bid | 1.0600 x 800 |
Ask | 1.1000 x 800 |
Day's range | 1.0600 - 1.1200 |
52-week range | 0.8960 - 5.6500 |
Volume | |
Avg. volume | 3,442,865 |
Market cap | 36.518M |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | 1.92 |
EPS (TTM) | 0.5740 |
Earnings date | 08 Aug 2022 - 12 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kin Communications Inc. ("Kin"), a leading full-service investor relations agency, has joined forces with NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen M.D.''), a leader in needle-free drug delivery, to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D's needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.
Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (